Healthcare Realty Trust price target lowered to $17 from $20 at BMO Capital

BMO Capital lowered the firm’s price target on Healthcare Realty Trust to $17 from $20 and keeps a Market Perform rating on the shares. The company’s investor day presentation unsurprisingly did not include FY24 earnings expectations or long-term growth targets post its Q2, the analyst tells investors in a research note. While Healthcare Realty was solid in highlighting operating synergies and clustering opportunities with near-term focus on driving occupancy and decreasing leverage, the market likely will be hesitate to give the company the benefit of the doubt given its past missteps, the firm added.